ESC Heart Failure (Oct 2022)

Impact analysis of heart failure across European countries: an ESC‐HFA position paper

  • Giuseppe M.C. Rosano,
  • Petar Seferovic,
  • Gianluigi Savarese,
  • Ilaria Spoletini,
  • Yuri Lopatin,
  • Fin Gustafsson,
  • Antoni Bayes‐Genis,
  • Tiny Jaarsma,
  • Magdy Abdelhamid,
  • Arantxa Gonzalez Miqueo,
  • Massimo Piepoli,
  • Carlo G. Tocchetti,
  • Arsen D. Ristić,
  • Ewa Jankowska,
  • Brenda Moura,
  • Loreena Hill,
  • Gerasimos Filippatos,
  • Marco Metra,
  • Davor Milicic,
  • Thomas Thum,
  • Ovidiu Chioncel,
  • Tuvia Ben Gal,
  • Lars H. Lund,
  • Dimitrios Farmakis,
  • Wilfried Mullens,
  • Stamatis Adamopoulos,
  • Michael Bohm,
  • Anna Norhammar,
  • Andreas Bollmann,
  • Amitava Banerjee,
  • Aldo P. Maggioni,
  • Adriaan Voors,
  • Alain Cohen Solal,
  • Andrew J.S. Coats

DOI
https://doi.org/10.1002/ehf2.14076
Journal volume & issue
Vol. 9, no. 5
pp. 2767 – 2778

Abstract

Read online

Abstract Heart failure (HF) is a long‐term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC‐HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs—in terms of quality of life—in European countries.

Keywords